IMP logo

Imexpharm Corporation Stock Price

HOSE:IMP Community·₫8.5t Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

IMP Share Price Performance

₫0
-48000.00 (-100.00%)
₫0
-48000.00 (-100.00%)
Price ₫0

IMP Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

0 Risks
2 Rewards

Imexpharm Corporation Key Details

₫2.4t

Revenue

₫1.3t

Cost of Revenue

₫1.2t

Gross Profit

₫858.6b

Other Expenses

₫304.4b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.98k
47.64%
12.47%
9.2%
View Full Analysis

About IMP

Founded
1997
Employees
1456
CEO
Dao Tran
WebsiteView website
www.imexpharm.com

Imexpharm Corporation operates as a pharmaceutical company in Vietnam. The company’s products include injectable antibiotics, oral antibiotics, cardiovascular, ophthalmology, musculoskeletal system, analgesic - anti-inflammatory - antipyretics, respiratory system, antihistamines and anti-allergy, central nervous system, digestive system, diabetes, anti-parasitic, external drugs, vitamins and minerals, and supplements. It is also involved in the import and export. The company was founded in 1997 and is headquartered in Cao Lãnh, Vietnam.

Recent IMP News & Updates

Recent updates

No updates

Imexpharm Corporation Competitors